Q1 Earnings Forecast for Revvity Issued By Leerink Partnrs

Revvity, Inc. (NYSE:RVTY - Free Report) - Research analysts at Leerink Partnrs cut their Q1 2025 EPS estimates for shares of Revvity in a research report issued to clients and investors on Friday, November 22nd. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings per share of $1.09 for the quarter, down from their prior forecast of $1.14. The consensus estimate for Revvity's current full-year earnings is $4.85 per share. Leerink Partnrs also issued estimates for Revvity's Q4 2025 earnings at $1.47 EPS.

Revvity (NYSE:RVTY - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.13 by $0.15. The firm had revenue of $684.10 million for the quarter, compared to the consensus estimate of $679.66 million. Revvity had a return on equity of 7.42% and a net margin of 9.34%. The firm's revenue was up 2.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.18 EPS.

RVTY has been the subject of several other reports. Leerink Partners lifted their price target on Revvity from $130.00 to $135.00 and gave the company an "outperform" rating in a research report on Thursday, October 17th. Robert W. Baird raised their price target on shares of Revvity from $136.00 to $138.00 and gave the company an "outperform" rating in a research report on Tuesday, November 5th. TD Cowen increased their target price on shares of Revvity from $141.00 to $144.00 and gave the stock a "buy" rating in a research note on Tuesday, November 5th. Jefferies Financial Group lifted their price target on Revvity from $115.00 to $125.00 and gave the company a "hold" rating in a research note on Monday, July 29th. Finally, Citigroup increased their price target on Revvity from $135.00 to $145.00 and gave the stock a "buy" rating in a research report on Tuesday, July 30th. Seven research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $131.73.

Revvity Stock Performance

Shares of RVTY stock traded up $2.63 during trading hours on Monday, hitting $114.66. The company's stock had a trading volume of 1,408,832 shares, compared to its average volume of 843,500. The company has a 50 day moving average of $120.53 and a 200 day moving average of $115.74. The stock has a market cap of $13.95 billion, a PE ratio of 55.39, a price-to-earnings-growth ratio of 2.80 and a beta of 1.05. The company has a current ratio of 3.56, a quick ratio of 2.97 and a debt-to-equity ratio of 0.40. Revvity has a 12-month low of $86.30 and a 12-month high of $129.50.

Hedge Funds Weigh In On Revvity

Several hedge funds have recently bought and sold shares of the company. Rothschild Investment LLC purchased a new position in Revvity in the second quarter valued at $25,000. Gladius Capital Management LP purchased a new stake in shares of Revvity during the 3rd quarter worth approximately $32,000. Continuum Advisory LLC grew its stake in Revvity by 2,972.7% during the 3rd quarter. Continuum Advisory LLC now owns 338 shares of the company's stock worth $43,000 after buying an additional 327 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Revvity by 74.2% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 392 shares of the company's stock valued at $41,000 after acquiring an additional 167 shares during the period. Finally, Avior Wealth Management LLC raised its holdings in shares of Revvity by 7,980.0% in the third quarter. Avior Wealth Management LLC now owns 404 shares of the company's stock valued at $52,000 after buying an additional 399 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company's stock.

Insider Buying and Selling

In related news, insider Tajinder S. Vohra sold 2,154 shares of Revvity stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $121.73, for a total value of $262,206.42. Following the completion of the sale, the insider now owns 19,652 shares in the company, valued at approximately $2,392,237.96. This trade represents a 9.88 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.60% of the stock is currently owned by company insiders.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 7th. Stockholders of record on Friday, January 17th will be given a $0.07 dividend. The ex-dividend date is Friday, January 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.24%. Revvity's dividend payout ratio (DPR) is presently 13.53%.

Revvity declared that its board has initiated a stock buyback program on Monday, November 4th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to buy up to 6.5% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board believes its stock is undervalued.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.